These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 30793786)

  • 1. Optimising the two-stage randomised trial design when some participants are indifferent in their treatment preferences.
    Walter SD; Turner RM; Macaskill P
    Stat Med; 2019 Jun; 38(13):2317-2331. PubMed ID: 30793786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of treatment preference effects in clinical trials when some participants are indifferent to treatment choice.
    Walter SD; Turner RM; Macaskill P; McCaffery KJ; Irwig L
    BMC Med Res Methodol; 2017 Feb; 17(1):29. PubMed ID: 28219326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficiencies of alternative preference-based designs for randomised trials.
    Walter SD; Bian M
    Stat Methods Med Res; 2020 Dec; 29(12):3783-3803. PubMed ID: 32703124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal allocation of participants for the estimation of selection, preference and treatment effects in the two-stage randomised trial design.
    Walter SD; Turner RM; Macaskill P; McCaffery KJ; Irwig L
    Stat Med; 2012 Jun; 31(13):1307-22. PubMed ID: 22362374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the treatment effect: Evaluating the effects of patient preferences in randomised trials.
    Walter SD; Turner R; Macaskill P; McCaffery KJ; Irwig L
    Stat Methods Med Res; 2017 Feb; 26(1):489-507. PubMed ID: 25213116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample Size and Power When Designing a Randomized Trial for the Estimation of Treatment, Selection, and Preference Effects.
    Turner RM; Walter SD; Macaskill P; McCaffery KJ; Irwig L
    Med Decis Making; 2014 Aug; 34(6):711-9. PubMed ID: 24695962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding.
    Cooper KG; Grant AM; Garratt AM
    Br J Obstet Gynaecol; 1997 Dec; 104(12):1367-73. PubMed ID: 9422014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taking a chance: How likely am I to receive my preferred treatment in a clinical trial?
    Walter SD; Blaha O; Esserman D
    Stat Methods Med Res; 2023 Mar; 32(3):572-592. PubMed ID: 36628522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised trials comparing different healthcare settings: an exploratory review of the impact of pre-trial preferences on participation, and discussion of other methodological challenges.
    Corbett MS; Watson J; Eastwood A
    BMC Health Serv Res; 2016 Oct; 16(1):589. PubMed ID: 27756285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conducting a two-stage preference trial: utility and challenges.
    Sidani S; Fox M; Epstein D
    Int J Nurs Stud; 2015 May; 52(5):1017-24. PubMed ID: 25736207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    Health Technol Assess; 2005 Sep; 9(35):1-186, iii-iv. PubMed ID: 16153352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size and power for a stratified doubly randomized preference design.
    Cameron B; Esserman DA
    Stat Methods Med Res; 2018 Jul; 27(7):2168-2184. PubMed ID: 27872194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences.
    Ali S; Hopkin G; Poonai N; Richer L; Yaskina M; Heath A; Klassen TP; McCabe C; ;
    Trials; 2021 Mar; 22(1):206. PubMed ID: 33712062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensions to the two-stage randomized trial design for testing treatment, self-selection, and treatment preference effects to binary outcomes.
    Cameron B; Peduzzi P; Esserman D
    Stat Med; 2018 Sep; 37(22):3147-3178. PubMed ID: 29855065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect.
    Heo M; Meissner P; Litwin AH; Arnsten JH; McKee MD; Karasz A; McKinley P; Rehm CD; Chambers EC; Yeh MC; Wylie-Rosett J
    Stat Methods Med Res; 2019 Feb; 28(2):626-640. PubMed ID: 29121828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and analysis of partially randomized preference trials with propensity score stratification.
    Wang Y; Li F; Blaha O; Meng C; Esserman D
    Stat Methods Med Res; 2022 Aug; 31(8):1515-1537. PubMed ID: 35469503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of participant and physician intervention preferences on randomized trials: a systematic review.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    JAMA; 2005 Mar; 293(9):1089-99. PubMed ID: 15741531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the influence of treatment preferences on attrition, adherence and outcomes: a protocol for a two-stage partially randomized trial.
    Sidani S; Fox M; Streiner DL; Miranda J; Fredericks S; Epstein DR
    BMC Nurs; 2015; 14():57. PubMed ID: 26557787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of participant preferences in unblinded randomized controlled trials.
    Floyd AH; Moyer A
    J Empir Res Hum Res Ethics; 2010 Jun; 5(2):81-93. PubMed ID: 20569152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of patient preference on the design and interpretation of clinical trials.
    Feine JS; Awad MA; Lund JP
    Community Dent Oral Epidemiol; 1998 Feb; 26(1):70-4. PubMed ID: 9511845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.